FDA Reproductive Division Deputy Is Ditropan XL Reviewer Shames
Executive Summary
FDA has named Daniel Shames, MD, as deputy director of its Division of Reproductive & Urologic Drug Products.
You may also be interested in...
Female Sexual Dysfunction And Andropause Could Be Advisory Cmte. Topics
A focus of FDA's Reproductive & Urologic Drug Products Division under Acting Director Daniel Shames, MD, could be female sexual dysfunction and andropause
Female Sexual Dysfunction And Andropause Could Be Advisory Cmte. Topics
A focus of FDA's Reproductive & Urologic Drug Products Division under Acting Director Daniel Shames, MD, could be female sexual dysfunction and andropause
FDA Antiviral Division's Jolson Will Be Acting ORM Director Starting Nov. 6
Antiviral Drug Products Division Director Heidi Jolson, MD, will take over as acting director of the Office of Review Management on Nov. 6.